Literature DB >> 26403856

Platelet proteomics in thalassemia: Factors responsible for hypercoagulation.

Shilpita Karmakar1, Debasis Banerjee2,3, Abhijit Chakrabarti4.   

Abstract

PURPOSE: Thalassemias can be defined as a group with inherited hemolytic anemia due to differential expressions of α and β globin genes. Hemoglobin E combined with β thalassemia (HbEβ) creates high oxidative stress in platelets producing different degrees of pathophysiological severity. Numerous cases of thalassemia have been reported with thromboembolic complications due to the hypercoagulable state, the mechanism underlying that is not yet well understood. EXPERIMENTAL
DESIGN: We have used 2DE and DIGE coupled with MALDI TOF/TOF-based MS identification and characterization of altered proteins in both splenectomized and nonsplenectomized HbEβ and β thalassemia to investigate the factors responsible for hypercoagulation.
RESULTS: The study revealed elevated levels of chaperones like HSP70, protein disulfide isomerase; oxidative stress proteins like peroxiredoxin2 and superoxide dismutase1 along with high ROS levels. Upregulation of translation initiation factor 5a observed in thalassemia is a novel finding and plays a protective role toward cell survival under oxidative stress. CONCLUSIONS AND CLINICAL RELEVANCE: The altered levels of chaperones and oxidative stress proteins indicate toward regulation of integrin binding and platelet activation under oxidative stress. Altogether, this comparative proteomics study of platelets in thalassemia could provide an insight into better understanding of the pathophysiology of the disease.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  2D gel electrophoresis; Hypercoagulation; MALDI MS; Oxidative stress; Platelets

Mesh:

Substances:

Year:  2015        PMID: 26403856     DOI: 10.1002/prca.201500049

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  4 in total

Review 1.  Proteomics in India: the clinical aspect.

Authors:  Somaditya Mukherjee; Arun Bandyopadhyay
Journal:  Clin Proteomics       Date:  2016-11-05       Impact factor: 3.988

2.  Platelet proteome reveals specific proteins associated with platelet activation and the hypercoagulable state in β-thalassmia/HbE patients.

Authors:  Puangpaka Chanpeng; Saovaros Svasti; Kittiphong Paiboonsukwong; Duncan R Smith; Kamonlak Leecharoenkiat
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

3.  Platelet protein biomarker panel for ovarian cancer diagnosis.

Authors:  Marta Lomnytska; Rui Pinto; Susanne Becker; Ulla Engström; Sonja Gustafsson; Christina Björklund; Markus Templin; Jan Bergstrand; Lei Xu; Jerker Widengren; Elisabeth Epstein; Bo Franzén; Gert Auer
Journal:  Biomark Res       Date:  2018-01-12

4.  Altered platelet proteome in lupus anticoagulant (LA)-positive patients-protein disulfide isomerase and NETosis as new players in LA-related thrombosis.

Authors:  Ingrid Pabinger; Maria Zellner; Lena Hell; Kristina Lurger; Lisa-Marie Mauracher; Ella Grilz; Christina Maria Reumiller; Georg Johannes Schmidt; Huriye Ercan; Silvia Koder; Alice Assinger; José Basilio; Johanna Gebhart; Cihan Ay
Journal:  Exp Mol Med       Date:  2020-01-20       Impact factor: 8.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.